18.04
1.59 (9.67%)
| Penutupan Terdahulu | 16.45 |
| Buka | 16.47 |
| Jumlah Dagangan | 436,924 |
| Purata Dagangan (3B) | 452,298 |
| Modal Pasaran | 801,927,424 |
| Harga / Jualan (P/S) | 75.68 |
| Harga / Buku (P/B) | 2.44 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Operasi (TTM) | -1,133.43% |
| EPS Cair (TTM) | -1.98 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.29% |
| Nisbah Semasa (MRQ) | 13.68 |
| Aliran Tunai Operasi (OCF TTM) | -53.21 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -34.85 M |
| Pulangan Atas Aset (ROA TTM) | -19.54% |
| Pulangan Atas Ekuiti (ROE TTM) | -30.20% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | BioAge Labs, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | 4.0 |
| Purata | 2.50 |
|
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| % Dimiliki oleh Orang Dalam | 3.63% |
| % Dimiliki oleh Institusi | 66.65% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |